Burning Rock Biotech (BNR) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Burning Rock Biotech Limited is set to delist its American Depositary Shares (ADSs) from the London Stock Exchange due to low trading volume and high maintenance costs, with an anticipated effect date around September 18, 2024. However, the company’s ADSs will remain available for trading on the Nasdaq Global Market. This move reflects Burning Rock’s strategic adjustments in response to market conditions while continuing their focus on next generation sequencing technology in precision oncology.
For further insights into BNR stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue